2. Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108:227–35.
3. Phi JH, Kim SK, Cho BK, et al. Long-term surgical outcomes of temporal lobe epilepsy associated with low-grade brain tumors. Cancer. 2009;115:5771–9.
4. Pallud J, Capelle L, Huberfeld G. Tumoral epileptogenicity: how does it happen? Epilepsia. 2013;54:Suppl 9. 30–4.
5. Ghareeb F, Duffau H. Intractable epilepsy in paralimbic Word Health Organization Grade II gliomas: should the hippocampus be resected when not invaded by the tumor? J Neurosurg. 2012;116:1226–34.
6. Englot DJ, Berger MS, Barbaro NM, Chang EF. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg. 2011;115:240–4.
7. Englot DJ, Han SJ, Berger MS, Barbaro NM, Chang EF. Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors. Neurosurgery. 2012;70:921–8. discussion 928.
8. Qiu B, Ou S, Song T, et al. Intraoperative electrocorticography-guided microsurgical management for patients with onset of supratentorial neoplasms manifesting as epilepsy: a review of 65 cases. Epileptic Disorder. 2014;16:175–84.
9. Mittal S, Barkmeier D, Hua J, et al. Intracranial EEG analysis in tumor-related epilepsy: evidence of distant epileptic abnormalities. Clin Neurophysiol. 2016;127:238–44.
10. Engel JJ, Van Ness P, Rasmussen T, Ojemann LM. Outcome with respect to epileptic seizures. Engel JJ, editor. Surgical treatment of the epilepsies. 2nd ed.. New York: Raven Press; 1993. p. 609–22.
11. Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol. 2005;58:525–32.
13. Dumpelmann M, Fell J, Wellmer J, Urbach H, Elger CE. 3D source localization derived from subdural strip and grid electrodes: a simulation study. Clin Neurophysiol. 2009;120:1061–9.
14. Pascual-Marqui RD. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol. 2002;24: Suppl D. 5–12.
15. Wagner M, Fuchs M, Kastner J. Evaluation of sLORETA in the presence of noise and multiple sources. Brain Topogr. 2004;16:277–80.
16. Hamer HM, Najm I, Mohamed A, Wyllie E. Interictal epileptiform discharges in temporal lobe epilepsy due to hippocampal sclerosis versus medial temporal lobe tumors. Epilepsia. 1999;40:1261–8.
17. Lee C, Kim JS, Jeong W, Chung CK. Usefulness of interictal spike source localization in temporal lobe epilepsy: electrocorticographic study. Epilepsy Res. 2014;108:448–58.
18. Mittal S, Shah AK, Barkmeier DT, Loeb JA. Systems biology of human epilepsy applied to patients with brain tumors. Epilepsia. 2013;54: Suppl 9. 35–9.
20. Rakhade SN, Yao B, Ahmed S, et al. A common pattern of persistent gene activation in human neocortical epileptic foci. Ann Neurol. 2005;58:736–47.
22. Chung CK, Lee SK, Kim KJ. Surgical outcome of epilepsy caused by cortical dysplasia. Epilepsia. 2005;46: Suppl 1. 25–9.
23. Im SH, Chung CK, Cho BK, et al. Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol. 2002;59:173–83.
24. Cossu M, Fuschillo D, Bramerio M, et al. Epilepsy surgery of focal cortical dysplasia-associated tumors. Epilepsia. 2013;54: Suppl 9. 115–22.
25. Chassoux F, Rodrigo S, Mellerio C, et al. Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology. 2012;79:1699–707.
26. Nolan MA, Sakuta R, Chuang N, et al. Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features. Neurology. 2004;62:2270–6.
27. Duffau H. Brain mapping in tumors: intraoperative or extraoperative? Epilepsia. 2013;54:Suppl 9. 79–83.